Search results
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell...
Medical Xpress· 3 hours agoUniversity of Kansas researchers in the lab of Anthony Fehr, associate professor of molecular...
A Scientist Says He Has the Evidence That We Live in a Simulation
Popular Mechanics· 1 day agoMany philosophers and scientists have pondered if we live in a simulated universe, and University of...
JN.1 COVID Variant Symptoms vs. Allergy Symptoms
Verywell Health via Yahoo News· 3 days agoThe JN.1 COVID variant has slightly different symptoms than other variants, as well as some differences when compared to seasonal allergies. Here's what...
COVID Shot Boosts Mucosal Immunity in Previously Infected People
MedPage Today· 3 days agoOnly 'traces' of spike-specific salivary antibodies found in vaccinated SARS-CoV-2-naive people
Scientists report longest known ‘extreme’ Covid infection in 72-year-old man
The Independent via Yahoo News· 2 days agoDoctors reported the case of a 72-year-old patient in the Netherlands who suffered from the novel...
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
Center for Infectious Disease Research and Policy· 1 day agoTaking the SARS-CoV-2 antiviral drug nirmatrelvir-ritonavir (Paxlovid) 3 to 5 days after COVID-19...
Engineers muffle invading pathogens with a 'molecular mask'
Phys.org· 1 day agoThe peptides that make up this gel prevent viruses such as SARS-CoV-2, which causes COVID-19, from attaching to and entering cells. Over ...
Long COVID Taste Loss May Not Involve Taste Buds
MedPage Today· 3 days agoStudy attempts to untangle taste and olfactory dysfunction 1 year after infection
Man dies after 613-day COVID-19 infection that underwent 50 mutations
Scripps News via AOL· 3 days agoAccording to the study, the man, whose identity was not disclosed, suffered from a blood disorder....
EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In...
Benzinga via Yahoo Finance· 8 hours agoThursday, Virax Biolabs Group Limited (NASDAQ: VRAX) announced it is launching ‘ImmuneSelect' within...